SIREN : 808299606
NATURAL SANTE FRANCE is a French company founded 11 years ago, specialized in the sector Gestion de fonds. Based in BORDEAUX (33800), this company of category ETI shows in 2024 a revenue of 527 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 527 454 € | 341 615 € | 352 366 € | 328 323 € | 239 738 € | 584 516 € | 300 000 € | 305 657 € | 303 784 € |
| Net income | -507 899 € | -8 109 131 € | -3 055 347 € | -42 188 € | -66 970 € | -169 108 € | 285 771 € | 454 177 € | 3 370 237 € |
| EBITDA | -238 € | -16 933 € | -17 929 € | -30 001 € | -30 359 € | -69 904 € | -794 542 € | -627 642 € | -249 490 € |
| Net margin | -96.3% | -2373.8% | -867.1% | -12.8% | -27.9% | -28.9% | 95.3% | 148.6% | 1109.4% |
In 2024, NATURAL SANTE FRANCE achieves revenue of 527 k€. Over the period 2015-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +6.3%. Vs 2023, growth of +54% (342 k€ -> 527 k€). After deducting consumption (0 €), gross margin stands at 527 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -238 €, representing -0.0% of revenue. Positive scissor effect: EBITDA margin improves by +4.9 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -508 k€ (-96.3% of revenue), which will impact equity.
527 454 €
527 454 €
-238 €
39 290 €
-507 899 €
-0.0%
The debt ratio (= Financial debt / Equity x 100) stands at -125%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -362%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
-125.066%
-362.03%
-48.262%
-26.198
In 2024, the debt ratio of NATURAL SANTE FRANCE (-125.07) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of NATURAL SANTE FRANCE (-362.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of NATURAL SANTE FRANCE (-26.20) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 921.08. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
921.083
-255307.563
In 2024, the liquidity ratio of NATURAL SANTE FRANCE (921.08) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of NATURAL SANTE FRANCE (-255307.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 33 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 62 days. Favorable situation: supplier credit is longer than customer credit by 29 days. Overall, WCR represents 321 days of revenue, i.e. 470 k€ to permanently finance. Over 2015-2024, WCR increased by +149%, requiring additional financing.
470 030 €
33 j
62 j
0 j
321 j
Based on 62 transactions of similar company sales
in 2024,
the value of NATURAL SANTE FRANCE is estimated at
160 564 €
(range 83 079€ - 447 074€).
The price/revenue ratio is 0.30x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare NATURAL SANTE FRANCE with other companies in the same sector:
The revenue of NATURAL SANTE FRANCE in 2024 is 527 k€.
NATURAL SANTE FRANCE recorded a net loss in 2024.
The headquarters of NATURAL SANTE FRANCE is located in BORDEAUX (33800), in the department Gironde.
The tax return of NATURAL SANTE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
NATURAL SANTE FRANCE operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.